SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Jaidev Sharma who wrote (933)3/25/1999 4:15:00 AM
From: Thure Meyer  Read Replies (1) | Respond to of 1837
 
I would defer an anlysis to those that understand drug production, marketing, distribution etc. My guess is that margin on drugs is much more than 10%, probably more like 50%+. But that is simply my guess..

How much future expectation will be built into the price over the next month is anyone's guess. Duramed still has to deliver the goods in terms of marketing and sales.

Thure


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News